The aim of this study was to assess the feasibility of using serial bronchoalveolar lavage fluids (BALFs) to characterize the course of cell damage and inflammation in the airways of pediatric patients with acute burn or inhalation injury. This was a prospective, longitudinal, descriptive pilot study conducted at the Burn and Pediatric Intensive Care Units in a tertiary care medical center. Six consecutively intubated and mechanically ventilated pediatric patients with acute inhalational injuries were studied. Serial BALF specimens from clinically indicated bronchoscopies were used to measure DNA and cytokine levels. BALF DNA levels for the six pediatric burn subjects were the highest within the first 72 hours after burn injury and declined thereafter. At the early stages after injury, BALF DNA levels (median [min, max] 3789 [1170, 11,917] ng/ml) were similar to those in adult burn patients and pediatric cystic fibrosis or bronchiectasis patients and was higher than those in pediatric recurrent pneumonia patients. BALF DNA levels in children and adults with inhalation injury correlated significantly with BALF interleukin-6, interleukin-8, and transforming growth factor-β1 levels. The patient with the most severe early visible airway mucosal damage and soot pattern at bronchoscopy, as well as the most extensive burns, also had the highest average early BALF DNA level (11,917 ng/ml) and the longest ventilator course and hospital stay. Procedures were well tolerated. In children with acute burn and inhalational injury, airway cellular damage and inflammation (reflected in high BALF DNA levels) appear to peak during the first 72 hours after burn or inhalation injury followed by a slow decline. Serial analysis of factors in airway secretions is feasible and has the potential to reveal important pathophyisiologic pathways and therapeutic targets for the treatment of acute inhalational injuries. (J Burn Care Res 2013;34:326-333)
In burn victims, inhalation injury remains a significant risk factor for mortality and respiratory morbidity, including airway obstruction and acute lung injury or acute respiratory distress syndrome. The mechanisms by which inhalation injury contributes to this risk are unclear. One hypothesis is that a massive influx of inflammatory mediators and cells (primarily DNA-rich neutrophils) results in direct injury to the airway, leading to production of secretions and airway obstruction with mucus and products of inflammatory cell breakdown including DNA. 1 Some existing therapies such as anti-inflammatory agents or DNAse might be rational in this setting. 2 These agents are often used in clinical practice, but there are few data specifically supporting a pathophysiologic rationale for their use. [2] [3] [4] Serial bronchoscopy is used at some burn care centers for assessment of the extent of inhalational injury and for therapeutic purposes to clear soot and cellular debris from airways. 5, 6 The latter may be especially important in children with inhalation injuries because their small airway caliber may make them more susceptible to airway obstruction. 7 Studies have demonstrated the importance of inflammatory cells and their breakdown products in the pathophysiology of cystic fibrosis (CF) in which DNA from necrotic neutrophils contributes to the viscosity of airway secretions that obstruct airways. 8, 9 There is evidence that the use of anti-inflammatory drugs or inhaled DNAse improves morbidity in CF. 2, 3, 10, 11 Inhaled DNAse has also been studied in mechanically ventilated pediatric patients with atelectasis and has been shown to decrease inflammation and improve atelectasis compared to mechanical ventilation maneuvers alone. 4, 12 However, the composition of airway secretions in children with inhalation injury has not been described.
We performed a pilot study investigating inflammatory and injury markers in airway secretions after burn injury, using serial bronchoalveolar lavage fluids (BALFs) from pediatric patients undergoing endotracheal intubation and bronchoscopies as part of their care after burn injuries. Our general goal was to assess the feasibility of quantifying serial markers of injury or inflammation in the setting of acute inhalational injuries in children. Our specific goals were to 1) measure the quantity of DNA in airway secretions as a marker of airway injury and inflammatory cell breakdown; 2) compare DNA levels from pediatric burn patients with those from relevant comparison populations; and 3) assess the relationship of BALF DNA levels to inflammatory factors and clinical parameters.
METHODS

Study Design and Patients
This was a single center, prospective, descriptive study in which we measured levels of DNA and inflammatory markers in BALF obtained during clinical care of pediatric patients who were intubated after acute burn and inhalational injuries over a 1-year period. Patients underwent one or more diagnostic/therapeutic flexible bronchoscopic examinations according to a standard protocol (see below) based on their clinical needs, as determined by the attending physician at the University of North Carolina (UNC) Hospitals/North Carolina Jaycee Burn Center. A sample of consecutive pediatric patients admitted during a 1-year period was planned. Excess BALF beyond that needed for clinical purposes was collected for the study and processed as described below. Additionally, clinical data regarding outcomes and severity (length of hospital and intensive care unit [ICU] stay, ventilator course duration, presence of infection, %BSA, and PaO 2 to FiO 2 ratios, if available) were collected, and digital images of the large airways were recorded for grading according to a previously published semiquantitative scale. 13 We compared study samples to samples obtained from children with CF or bronchiectasis undergoing diagnostic bronchoscopy for lower airway cultures and children with chronic cough or wheeze not due to bronchiectasis or CF who were undergoing diagnostic bronchoscopy. Samples from these pediatric comparison groups were available from a separate research study.
14 Finally, we obtained bronchial washing samples from a series of intubated adult patients with similar burn/inhalational injuries as the children in the study.
The study was approved by the UNC Biomedical Institutional Review Board, and informed consent was obtained from all adult subjects or their legal representatives and from the parents of all pediatric subjects.
Bronchoscopy Protocol
Flexible bronchoscopy and bronchoalveolar lavage (BAL) were performed according to a protocol developed jointly by the burn center and the UNC Children's Airway Center. All patients with suspected inhalation injury based on history and physical findings (eg, prolonged exposure to fire in an enclosed space or presence of carbonaceous debris around the nose and/or mouth) underwent bronchoscopic evaluation within 24 hours after admission to assess for the presence of inhalation injury. To perform the bronchoscopy, the bronchoscope was inserted via the endotracheal tube, and the distal trachea and airways were inspected to the level of the lobar bronchi. BAL was performed using standardized lavage volumes as previously described. 15 The location of the initial lavage was in the lobe that appeared to be the most heavily involved with soot or mucosal damage, but lavages were done in multiple locations. However, if no distinct "worst" location was apparent, then the initial lavage was done in the right middle lobe or lingula. At subsequent procedures, the same approach was taken, but BALF for research purposes was processed only for the lobe identified as the worst at the initial procedure for each patient. The frequency and timing of subsequent procedures was at the discretion of the attending burn center physician and depended on several factors including the initial soot burden, the severity of initial mucosal damage, and the degree of difficulty with mucus clearance.
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In adult burn patients, a similar bronchoscopy protocol was used, but lavages were done in both the left and right mainstem bronchi in all patients. At each procedure, an initial 20 ml aliquot was instilled, then suctioned back and collected for research purposes, with subsequent aliquots at the discretion of the care team for therapeutic indications. BALs for clinical indications in pediatric comparison groups were done as described above for pediatric burn patients, but on only a single occasion and typically in only one lobe.
Video images of the airways recorded at bronchoscopy were scored according to the scale described by Chou et al 13 in which the central airway's appearance is graded as G0 (negative), G1 (mild edema and hyperemia ± soot), G2 (severe edema and hyperemia ± soot), or G3 (ulcerations, necrosis, absence of bronchial secretions, dry).
BALF Processing
BALF specimens were processed within 24 hours of specimen collection. Previous studies have suggested that BALF can be stored on ice for up to 24 hours without significant impact on specimen viability. 15, 16 Briefly, total cell count was taken, and cytocentrifuged BALF was stained with modified Wright stain for differential cell counts. The remaining BALF was then centrifuged at 300g, and the resulting cell-free supernatant was stored at −80°C for subsequent mediator measurements. BALF double-stranded DNA (dsDNA) was quantified using QuantIt ™ PicoGreen ® dsDNA Assay Kit (Invitrogen ™ Ltd, Eugene, OR), a fluorescent nucleic acid stain, according to the manufacturer's instructions. BALF interleukin (IL)-6, IL-8, and transforming growth factor-β1 (TGF-β1) assays were performed using commercial enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions. These mediators were selected as representative markers for inflammation and injury repair. 9, 17, 18 
Statistical Methods
For descriptive purposes, data comparisons among multiple groups were done using a nonparametric one-way analysis of variance with Dunn's posttest. Correlations between DNA and cytokine levels in BALF were analyzed using linear regression and logtransformed data. All statistical comparisons were done using GraphPad Prism (GraphPad Prism Software, Inc., La Jolla, CA). P < .05 was considered statistically significant throughout.
RESULTS
Patient Characteristics
During the study period, we collected serial BALF from six children who required endotracheal intubation after acute burn and inhalational injuries. All children were healthy prior to their acute injury. Some of their clinical characteristics are shown in Table 1 . 19 Their ages at the time of injury ranged from 2 to 16 years. Three of the children were injured in house fires, two in motor vehicle crashes, and one from a paint can explosion. All six children underwent an initial bronchoscopy within the first 24 hours after injury. Subsequent bronchoscopies were dictated by the initial severity of injury and subsequent clinical course, as per routine clinical protocol. Percentage BSA burn in the six children ranged from 13 to 50%. The degree of initial visual evidence for inhalational injury varied from mild to severe. One patient was transferred to another burn center on postinjury day 6 and was lost to follow-up. For the remaining five children, the length of stay in ICU ranged from 14 to 167 days, whereas the overall hospital stay ranged from 28 to 254 days. Subject six, who had both the highest initial bronchoscopic injury grade and the most extensive burns in this series, also had the lowest minimum PaO 2 :FiO 2 ratio and longest ventilator course and hospital stay (Table 1) . No complications were noted for any of the bronchoscopy procedures.
DNA and Inflammatory Markers in BALF
DNA quantity in BALF for these six patients generally showed the highest levels within the first several days after burn injury, and declined thereafter (Figure 1) , except for patient 6 who had the most severe injury ( Table 1) . As shown in Figure 1 , the number and timing of bronchoscopies varied among patients according to clinical indication. Cairns et al 20 have shown in animal models that cytokine responses at <3 days postburn injury differ from those obtained at later time points. For a descriptive analysis, we averaged "early" (<3 days) data for each subject, when more than one procedure was done during that time frame. Figure 2 shows that early BALF DNA levels from pediatric burn patients (median [ 16 ,820] ng/ml). DNA levels generally followed the pattern seen for other markers of inflammation.
"Early" BALF showed a predominance of neutrophils (71 ± 10% neutrophils; 1.29 ± 0.68 × 10 6 Figure 1 . Bronchoalveolar lavage fluid (BALF) DNA over time postinjury for six pediatric burn patients. Day 0 is the day of the injury. Each line represents a separate patient (one G1 patient had a single sample obtained on day 1). For reference, the horizontal broken line at 500 ng/ml is near both the upper limit for the pediatric recurrent pneumonia comparison group and the lower limit for the pediatric cystic fibrosis (CF) comparison groups in the study. Figure 2 . Bronchoalveolar lavage fluid (BALF) DNA levels in pediatric burn patients compared to several other patient groups. Averaged DNA levels in the first 72 hours after injury in six children with burns (ped burn acute) vs five children with chronic bronchiectasis (ped bronchiectasis), 11 adult burn victims (adult burn acute), and five pediatric patients with recurrent pneumonia but without bronchiectasis (ped rec pneumonia). *P < .05 vs pediatric recurrent pneumonia group.
May/June 2013 neutrophils/ml). In a subset of three of the children with burns, and in serial specimens from 11 adult burn patients, there were sufficient BALF samples remaining to measure levels of several inflammatory cytokines. Figure 3 shows that IL-8, IL-6, and TGF-β1 levels for both the adult and pediatric patients all correlated significantly with DNA in these samples (IL-6: r 2 = .416, P = .007; IL-8: r 2 = .742, P < .001; TGF-β 1 : r 2 = .65, P < .001 for pediatric patients). The adult and pediatric data are shown together for descriptive comparison.
DNA and Clinical Indicators
Clinical grading of inhalational injury is typically done at initial presentation. For the purposes of our study, we assessed the relationship between BALF DNA levels and bronchoscopic evidence for inhalational injury at all available time points, using a semiquantitative injury scale of bronchoscopic images as described in the Methods section. There were a total of 16 days for which both video images and BALF DNA data were available among the six pediatric patients. No grade G0 images were observed. 275 ng/ml postinjury day 1), greatest %BSA burn (50%), and the longest ICU and hospital length of stay in the series (Figure 4) . It is interesting to note that a second increase in dsDNA appeared to occur following a diagnosis of pneumonia in this patient.
DISCUSSION
In a small series of pediatric burn patients, we have described time courses for the levels of total DNA and inflammatory factors in lower respiratory secretions and their relationships with clinical factors. Our study suggests that studies of airway secretions in the setting of acute inhalational injuries in children are feasible because bronchoscopy and BAL were well tolerated, and several biomarkers of interest were easily measurable. Our finding of markedly elevated early DNA levels in the child with the most severe inhalation injury and clinical course, coupled with the overall correlation between DNA and inflammatory cytokines, suggests that early bronchoscopy-derived markers of inflammation or injury might predict clinical outcomes. This conclusion requires replication of our findings in larger studies.
Our patients had variation in the extent of cutaneous burns. As has been well described in other studies, cutaneous burns may have distant organ effects (eg, acute lung injury) that are independent of inhalation injury. 21, 22 These effects may be responsible for a portion of the inflammatory response seen in these subjects. A larger study could further elucidate this relationship. Our primary specific finding was that BALF DNA levels were elevated early after burn or inhalation injury and generally correlated with the cytokine markers of inflammation and injury, IL-6, IL-8, and TGF-β1. Although elevated early BALF levels of inflammatory mediators IL-6 and IL-8 have been reported in a recent study of adult burn/inhalation victims, 23 we believe these are the first pediatric data describing airway responses to this type of acute respiratory injury. Potential sources of DNA in airway secretions include directly damaged epithelial cells and inflammatory cells responding to injury or infection. 1, 9, 11 For example, the second elevation of DNA in patient 6 following the diagnosis of pneumonia might have been because of neutrophil responses to infection. Our data cannot differentiate among these cellular sources because all of the factors measured could be derived from multiple cell types.
The DNA levels observed in this series were similar to those from a comparison group of children with bronchiectasis ( Figure 2 ) and also similar to those reported in the literature for children with CF. 8, 9 In CF, DNA from lysed neutrophils is the major source of viscosity in airway secretions, [8] [9] [10] and treatment with DNAse has shown some clinical benefit in terms of improvement in airways obstruction. 3, 11 Although the pathophysiology of CF and inhalation injury are obviously different, our finding of BALF DNA levels in the "CF range" suggests a rationale to use DNAse to reduce risk of airway obstruction early in the setting of acute inhalational injury. Controlled trials are required to provide evidence that this is clinically effective. Additionally, future studies may better allow for grading of the secretion pattern and determination of clinical indications for mucolytics.
Our study relied on airway secretions obtained during bronchoscopies done as part of a clinical protocol at our center. Bronchoscopy has been described as having diagnostic and potentially therapeutic usefulness in the setting of acute burns and inhalational injury, 5, 6, 24, 25 and two recent studies describe data similar to ours from bronchoscopic lavage specimens in an inhalational injury population. 26, 27 Our clinical experience suggests that bronchoscopy and BAL are well tolerated in mechanically ventilated children after burn and inhalational injury. Although limited, our data suggest the possibility that the bronchoscopic appearance of the airways (soot, edema, hyperemia, necrosis, etc.) may reflect the severity of mucosal injury or inflammation and may further be reflected in specific BALF mediator concentrations.
Clinical research in the setting of critical illness is inherently difficult, and additional limitations are present when investigating critically injured children. Although the management strategy during the study period was fairly uniform, our series of patients was heterogeneous regarding type and amount of specific toxins inhaled, patient size, and sample availability based on clinical management decisions. Additionally, variable dilution of native airway secretions could well affect our data, and estimating this dilution is problematic especially in the setting of the rapidly changing mucosal permeability. [28] [29] [30] We attempted to minimize some of these sources of variability by comparing same-lobe BALF in individual children over time and adjusting BAL aliquots by patient size, but conclusions are limited by the small sample size, given these sources of data heterogeneity. Finally, although all samples were processed within 24 hours, there was some variability in the timing of the processing of samples because of the unpredictable timing of patient presentation, which may have introduced some variability in the results.
Children may have an elevated risk for respiratory complications from thermal and inhalational injuries. The pathophysiology of responses to these injuries is not well understood in this age group. Despite limitations, our data suggest that clinically derived specimens such as those we describe may serve as a useful resource for research aiming to translate concepts from experimental models to the clinical arena.
